Associate Teaching Professor, Bioengineering
Director, Masters In PHARBE

Robbie Wong

Roberta Wong

Biology Major UC Davis- early admission to UCSF School of Pharmacy
PharmD UCSF School of Pharmacy
Clinical Residency, UCSF School of Pharmacy
Golden Gate Society of Health-System Pharmacists Intern Award
UCSF Residency Award for Research Project (Prophylactic antibiotic use during Cardiovascular Surgery)
Fellow, American Society of Health-System Pharmacists
US Assistant Secretary of Health Award for Educating Pharmacists on Treatment of HIV Infection
Fellow, California Society of Health-System Pharmacists
PHARBE 502 Drug Discovery and Design in Drug Development
PHARBE 503 Clinical Drug Development
PHARBE 506B Pharmaceutical Bioengineering Seminar
PHARBE 513 Clinical Development
PHARBE 522 Molecular Targets and Drug Classes
BIOE 532 Professional skills development
  1. 2016, Wong RJ, Foote MA. Biosimilars: Basic Information for the Medical Writer. AMWA J 2016:31(3): 99-105, 131.
  2. 2012, Wong R. Drug Accountability in Clinical Trials. GxP Lifeline- Pharmaceutical Online Publication. 2012; May.
  3. 2006, Wong R, Thakkar A, Foote MA. Taxane therapy for the treatment of metastatic breast cancer: information for hospital pharmacists. Eur J Hosp Pharm. 2006; 12:6-7.
  4. 2000, Campbell TB, Sevin A, Coombs RW, Peterson GC, Rosandich M, Kuritzkes DR, Mladenovic J, Landay A, Wong, R, Ambrusso D, Miles S, Pomerantz RJ, Schooley RT and the ACTG 285 Study Team. Changes in Human Immunodeficiency Virus Type I Virus Load During Mobilization and Harvesting of Hemopoietic Progenitor Cells. Blood 2000; 95(1): 48-55.
  5. 2000, Schooley, RT, Mladenovic J, Sevin A, Chiu S, Miles SA, Pomerantz RJ, Campbell TB, Bell D, Ambruso D, Wong, R, Landay A, Coombs RW, Fox L, Kamoun M, Jacovini J and the AIDS Clinical Trials Group 285 Study Team. Reduced Mobilization of CD34+ Stem Cells in Advanced Human Immunodeficiency Virus Type 1 Disease. J Inf Dis 2000; 181:148-57.
  6. 1999, Wong RJ. Treatment of HIV-related neutropenia. Am J Heath-System Pharm 1999;56(S5):S17-S20.
  7. 1998, Kuritzkes, D., Parenti, D., Ward, D.J., Rachlis, A., Wong, R., Mallon, K., Rich, W, Jacobson, M. Filgrastim (r-met Hu G-CSF) Prevents severe Neutropenia and Reduces Infective Morbidity in Patients with Advanced HIV Infection: Results of a Randomized, Multicenter Controlled Trial. AIDS 1998; 12:65-74.
  8. 1998, Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y. A Placebo-controlled trial of the Immune Modulator, Lentinan, in HIV-Positive Patients: a phase I/II Trial. J Med 1998; 29(5-6):305-30.
  9. 1995, Marinol Investigators Group (Wong, R). Dronabinol as a Treatment for Anorexia associated with Weight Loss In Patients with AIDS. J Pain Symptom Manage 1995; 10:89-97.
  10. 1990, Leoung GS, Feigal DW, Montgomery AB, et al. (Wong R) Aerosolized Pentamidine for Prophylaxis Against Pneumocystis Carinii Pneumonia. N Engl J Med 323(12):769-75.
  11. 1990, Wong, RJ. Glove Selection for Handling Cytotoxic and Hazardous Drugs. (Ltr) American Journal of Hospital Pharmacy 47:2459.
  12. 1990, Wong, RJ. HIV-Related Pharmacology in AIDS Knowledge Base. Cohen PT, Sande MA, Volberding PA(Eds) The Medical Publishing Group, Waltham, MA.
  13. 1989, Wong RJ. Parallel track for investigational AIDS drugs. Am J Hosp Pharm; 46:2249-50.
  14. 1989, Wong RJ. Assessing The Pharmacy Practitioner’s Need for AIDS education. J Cont Ed Health Prof;9:35-42.
  15. 1989, Abrams DI, Kuno S, Wong R, et al. Oral Dextran Sulfate(UA001) in the Treatment of Acquired Immunodeficiency Syndrome(AIDS) and AIDS-Related Complex. Ann Intern Med; 110:183-188.
  16. 1988, Wong RJ and Volberding PA. “Providing Clinical Pharmacy Services in an Outpatient AIDS-Oncology Clinic”. American Journal of Hospital Pharmacy; 45:2351-54.
  17. Kaplan LD, Wolfe PR, Volberding PA, Feorino P, Abrams DI, Levy JA, Wong R, Kaufman L, and Gottlieb MS Lack of response to suramin in patients with AIDS and AIDS-related complex. Am J Med: 1987:82(3 Part 2):615-620.